Vesper Bio ApS: Financial statements 2017
CVR: 32879861
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -2,680,191 compared with DKK -4,003,407 the year before. Equity in the 2017 report amounted to DKK 7,885,531. The solvency ratio was 87.8%.
- Profit/Loss
- DKK -2,680,191
- Equity
- DKK 7,885,531
- Total Assets
- DKK 8,981,023
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -2.7 mio. | 7.9 mio. | 0 |
| 2016 | - | - | -4 mio. | 3.1 mio. | - |
| 2015 | - | - | -6.1 mio. | 7.1 mio. | - |
| 2014 | - | - | -6.9 mio. | 5.6 mio. | - |
| 2013 | - | - | -2.6 mio. | 12.6 mio. | - |
Official annual report
Keep an eye on Vesper Bio ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 15, 2017, 75PMK Holding ApS is registered as an owner of Vesper Bio ApS with an ownership share of 20%.
Vesper Bio ApS has published its annual report for 2016. The net result was DKK -4,003,407.
About Vesper Bio ApS
Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity in the 2025 report amounted to DKK -227,433,239.